A key federal panel Wednesday recommended the Food and Drug Administration approve the first new weight-loss drug in more than a decade.
At the conclusion of a day-long hearing, the FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted 20-2 to endorse a request from Vivus to approve the drug Qnexa. The same panel gave a thumbs-down to Qnexa in 2010.
Qnexa is a combination of two generic drugs that are already on the market:
Originally published on Tue January 17, 2012 1:25 pm
Credit Peter Kramer / ASSOCIATED PRESS
There were hints that all was not well in Paula Deen's Southern-fried world. Last November, when NPR correspondent Allison Aubrey asked Deen if she'd ever do healthier versions of her greasy, sugar-laden fare, Deen said: "As I age, and get older and I get 'different things' that I have to battle physically — it may, you know, resonate closer to home for me."
Second of two stories, which are part of an ongoing series on obesity in America. The first part begins in August as students start their weight-loss journey at Wellspring Academy, a boarding school in Brevard, N.C. The second checks in with students in late October.